U.S. Markets closed

Encompass Compliance Corporation (ENCC) Announces Financial Gains by a Key Customer

CHARLOTTE, North Carolina, April 4, 2017 /PRNewswire/ --

Encompass Compliance Corp. (OTC PINK: ENCC) has compiled critical data of the savings, by a fortune 500 Customer that has over 100,000 employees in the U.S.

This respective company conducted a 6-state pilot implementing Encompass Compliance Corporation's Risk Shield services and "the results were amazing," said the customer. After just 6 months, the company's drug and alcohol claims were reduced 20%, resulting in a $6.5 million savings on claim pay outs. The results were so impressive they have decided to expand the program to more states. This was a post-accident only pilot testing for some key drugs such as: THC, alcohol, cocaine, amphetamines, methamphetamines, opiates, benzodiazepines, propoxyphene, PCP, oxycodone, morphine and ecstasy. "Compliance is the key, but in addition to compliance you must aggressively pursue the benefits that exist for employers, which can only be accomplished if state rules are followed. Helping our customers follow the rules is what we do." says Encompass Co-Founder and CRO, Bill Judge.

About Encompass Compliance Corp.

Encompass Compliance Corp. is the most comprehensive provider of workplace drug and alcohol testing compliance services, with over 30 years of experience. We are dedicated to providing employers with the tools necessary to mitigate regulatory and compliance risk. Our Risk Shield solution provides organizations with up to date policies, a comprehensive resource center and real-time monitoring for drug and alcohol testing orders.

Safe Harbor Statement: 
This press release may include predictions, estimates, opinions or statements that might be considered "forward-looking" under the provisions of the Private Securities Litigation Reform Act of 1995. Statements generally identified by phrases such as the Company or its management "believes," "expects," "forecasts," "estimates," or other words or phrases are forward-looking.

For further information
Richard Sharp